{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Enasidenib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Enasidenib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Enasidenib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "enasidenib",
    "trial_2_text": "Enasidenib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Enasidenib Supplement: 60 participants will take Enasidenib 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Enasidenib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Enasidenib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "78": 0.3304644823074341,
      "87": 0.30628034472465515,
      "189": 0.2792057394981384,
      "188": 0.23558619618415833,
      "123": 0.22110715508460999,
      "173": 0.2196182757616043,
      "20": 0.1907990574836731,
      "9": 0.17621681094169617,
      "17": 0.1620253622531891,
      "228": 0.15647517144680023,
      "21": 0.15469437837600708,
      "64": 0.15298497676849365,
      "177": 0.14965592324733734,
      "49": 0.1440281867980957,
      "46": 0.14053480327129364,
      "68": 0.13803061842918396,
      "67": 0.13800682127475739,
      "239": 0.13141421973705292,
      "77": 0.12979979813098907,
      "200": 0.12684929370880127,
      "37": 0.12637223303318024,
      "104": 0.12423533201217651,
      "29": 0.12309172004461288,
      "350": 0.12299995869398117,
      "79": 0.11051872372627258,
      "243": 0.1044488400220871,
      "30": 0.1030658483505249,
      "14": 0.10229717195034027,
      "2": 0.10225538164377213,
      "114": 0.1016254797577858,
      "38": 0.10100202262401581,
      "151": 0.0982045903801918,
      "126": 0.09701743721961975,
      "193": 0.09602636098861694,
      "86": 0.09195775538682938,
      "179": 0.0896913930773735,
      "76": 0.08863663673400879,
      "180": 0.08709526807069778,
      "396": 0.08491943776607513,
      "27": 0.08432110399007797,
      "261": 0.08413735032081604,
      "101": 0.08384929597377777,
      "85": 0.08268949389457703,
      "191": 0.08228196948766708,
      "116": 0.08104684203863144,
      "131": 0.0809469074010849,
      "72": 0.08039189130067825,
      "194": 0.0772973969578743,
      "139": 0.07703961431980133,
      "5": 0.0766308456659317,
      "466": 0.07657462358474731,
      "102": 0.07630961388349533,
      "61": 0.07622867077589035,
      "441": 0.07488463819026947,
      "147": 0.07485121488571167,
      "341": 0.06856565177440643,
      "282": 0.06765516102313995,
      "18": 0.06643815338611603,
      "35": 0.06437680125236511,
      "269": 0.0627390444278717,
      "355": 0.062135979533195496,
      "253": 0.06104481220245361,
      "286": 0.060487836599349976,
      "122": 0.06001584604382515,
      "69": 0.059211794286966324,
      "204": 0.05899902433156967,
      "28": 0.05869623273611069,
      "249": 0.05819709226489067,
      "276": 0.05787088721990585,
      "96": 0.05682399496436119,
      "98": 0.054804522544145584,
      "361": 0.05444616079330444,
      "33": 0.05400075018405914,
      "36": 0.053491804748773575,
      "97": 0.05254509672522545,
      "82": 0.051916733384132385,
      "15": 0.05117998272180557,
      "288": 0.05115855857729912,
      "454": 0.051079846918582916,
      "75": 0.04938175901770592,
      "211": 0.049257293343544006,
      "268": 0.0485721156001091,
      "136": 0.04851384088397026,
      "356": 0.04799247160553932,
      "31": 0.04679771512746811,
      "212": 0.046508509665727615,
      "422": 0.046251080930233,
      "164": 0.04622865840792656,
      "382": 0.045696284621953964,
      "186": 0.04569223150610924,
      "132": 0.044442083686590195,
      "130": 0.04332440719008446,
      "257": 0.04235300421714783,
      "371": 0.04214850068092346,
      "535": 0.041695866733789444,
      "352": 0.041661638766527176,
      "92": 0.04155080020427704,
      "152": 0.04075515270233154,
      "187": 0.04038775712251663,
      "256": 0.04019947350025177
    },
    "trial_2_ae": {
      "78": 0.3304644823074341,
      "87": 0.30628034472465515,
      "189": 0.2792057394981384,
      "188": 0.23558619618415833,
      "123": 0.22110715508460999,
      "173": 0.2196182757616043,
      "20": 0.1907990574836731,
      "9": 0.17621681094169617,
      "17": 0.1620253622531891,
      "228": 0.15647517144680023,
      "21": 0.15469437837600708,
      "64": 0.15298497676849365,
      "177": 0.14965592324733734,
      "49": 0.1440281867980957,
      "46": 0.14053480327129364,
      "68": 0.13803061842918396,
      "67": 0.13800682127475739,
      "239": 0.13141421973705292,
      "77": 0.12979979813098907,
      "200": 0.12684929370880127,
      "37": 0.12637223303318024,
      "104": 0.12423533201217651,
      "29": 0.12309172004461288,
      "350": 0.12299995869398117,
      "79": 0.11051872372627258,
      "243": 0.1044488400220871,
      "30": 0.1030658483505249,
      "14": 0.10229717195034027,
      "2": 0.10225538164377213,
      "114": 0.1016254797577858,
      "38": 0.10100202262401581,
      "151": 0.0982045903801918,
      "126": 0.09701743721961975,
      "193": 0.09602636098861694,
      "86": 0.09195775538682938,
      "179": 0.0896913930773735,
      "76": 0.08863663673400879,
      "180": 0.08709526807069778,
      "396": 0.08491943776607513,
      "27": 0.08432110399007797,
      "261": 0.08413735032081604,
      "101": 0.08384929597377777,
      "85": 0.08268949389457703,
      "191": 0.08228196948766708,
      "116": 0.08104684203863144,
      "131": 0.0809469074010849,
      "72": 0.08039189130067825,
      "194": 0.0772973969578743,
      "139": 0.07703961431980133,
      "5": 0.0766308456659317,
      "466": 0.07657462358474731,
      "102": 0.07630961388349533,
      "61": 0.07622867077589035,
      "441": 0.07488463819026947,
      "147": 0.07485121488571167,
      "341": 0.06856565177440643,
      "282": 0.06765516102313995,
      "18": 0.06643815338611603,
      "35": 0.06437680125236511,
      "269": 0.0627390444278717,
      "355": 0.062135979533195496,
      "253": 0.06104481220245361,
      "286": 0.060487836599349976,
      "122": 0.06001584604382515,
      "69": 0.059211794286966324,
      "204": 0.05899902433156967,
      "28": 0.05869623273611069,
      "249": 0.05819709226489067,
      "276": 0.05787088721990585,
      "96": 0.05682399496436119,
      "98": 0.054804522544145584,
      "361": 0.05444616079330444,
      "33": 0.05400075018405914,
      "36": 0.053491804748773575,
      "97": 0.05254509672522545,
      "82": 0.051916733384132385,
      "15": 0.05117998272180557,
      "288": 0.05115855857729912,
      "454": 0.051079846918582916,
      "75": 0.04938175901770592,
      "211": 0.049257293343544006,
      "268": 0.0485721156001091,
      "136": 0.04851384088397026,
      "356": 0.04799247160553932,
      "31": 0.04679771512746811,
      "212": 0.046508509665727615,
      "422": 0.046251080930233,
      "164": 0.04622865840792656,
      "382": 0.045696284621953964,
      "186": 0.04569223150610924,
      "132": 0.044442083686590195,
      "130": 0.04332440719008446,
      "257": 0.04235300421714783,
      "371": 0.04214850068092346,
      "535": 0.041695866733789444,
      "352": 0.041661638766527176,
      "92": 0.04155080020427704,
      "152": 0.04075515270233154,
      "187": 0.04038775712251663,
      "256": 0.04019947350025177
    }
  },
  "safety": {
    "trial_1_safety": 0.4174429476261139,
    "trial_2_safety": 0.4174429476261139
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.47959062457084656
  }
}